The frequency of KIR2DL2-HLA-C1 was significantly higher in younger patients with HCC (28.8% versus 16.5%; P = 0.039; OR = 2.05) when KIR-HLA combinations were examined between younger patients with HCC and those without. This evidence concerns the gene KIR3DL1 and hepatocellular carcinoma.